82 related articles for article (PubMed ID: 20331434)
1. Novel mechanism for regulation of plasma platelet-activating factor acetylhydrolase expression in mammalian cells.
Gardner AA; Reichert EC; Alexander TS; Topham MK; Stafforini DM
Biochem J; 2010 May; 428(2):269-79. PubMed ID: 20331434
[TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor inactivation by local expression of platelet-activating factor acetyl-hydrolase modifies tumor vascularization and growth.
Biancone L; Cantaluppi V; Del Sorbo L; Russo S; Tjoelker LW; Camussi G
Clin Cancer Res; 2003 Sep; 9(11):4214-20. PubMed ID: 14519648
[TBL] [Abstract][Full Text] [Related]
3. Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection.
Caini P; Guerra CT; Giannini C; Giannelli F; Gragnani L; Petrarca A; Solazzo V; Monti M; Laffi G; Zignego AL
J Viral Hepat; 2007 Jan; 14(1):22-8. PubMed ID: 17212640
[TBL] [Abstract][Full Text] [Related]
4. Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticles.
Mitsios JV; Vini MP; Stengel D; Ninio E; Tselepis AD
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1907-13. PubMed ID: 16728656
[TBL] [Abstract][Full Text] [Related]
5. The proangiogenic phenotype of tumor-derived endothelial cells is reverted by the overexpression of platelet-activating factor acetylhydrolase.
Doublier S; Ceretto M; Lupia E; Bravo S; Bussolati B; Camussi G
Clin Cancer Res; 2007 Oct; 13(19):5710-8. PubMed ID: 17908960
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor acetylhydrolase: selective inhibition by potent n-alkyl methylphosphonofluoridates.
Quistad GB; Fisher KJ; Owen SC; Klintenberg R; Casida JE
Toxicol Appl Pharmacol; 2005 Jun; 205(2):149-56. PubMed ID: 15893542
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma non-esterified fatty acids and platelet-activating factor acetylhydrolase are associated with susceptibility to atherosclerosis in mice.
Singh U; Zhong S; Xiong M; Li TB; Sniderman A; Teng BB
Clin Sci (Lond); 2004 Apr; 106(4):421-32. PubMed ID: 14717654
[TBL] [Abstract][Full Text] [Related]
8. [Plasma platelet-activating factor acetylhydrolase (PAF-AH) deficiency as a risk factor for stroke].
Satoh K
Brain Nerve; 2008 Nov; 60(11):1319-24. PubMed ID: 19069165
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease.
Ninio E; Tregouet D; Carrier JL; Stengel D; Bickel C; Perret C; Rupprecht HJ; Cambien F; Blankenberg S; Tiret L
Hum Mol Genet; 2004 Jul; 13(13):1341-51. PubMed ID: 15115767
[TBL] [Abstract][Full Text] [Related]
10. Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2).
Stafforini DM
Cardiovasc Drugs Ther; 2009 Feb; 23(1):73-83. PubMed ID: 18949548
[TBL] [Abstract][Full Text] [Related]
11. Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis.
Gomes RN; Bozza FA; Amâncio RT; Japiassú AM; Vianna RC; Larangeira AP; Gouvêa JM; Bastos MS; Zimmerman GA; Stafforini DM; Prescott SM; Bozza PT; Castro-Faria-Neto HC
Shock; 2006 Jul; 26(1):41-9. PubMed ID: 16783197
[TBL] [Abstract][Full Text] [Related]
12. PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin.
Papavasiliou EC; Gouva C; Siamopoulos KC; Tselepis AD
Nephrol Dial Transplant; 2006 May; 21(5):1270-7. PubMed ID: 16421163
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis for susceptibility of plasma platelet-activating factor acetylhydrolase to oxidative inactivation.
MacRitchie AN; Gardner AA; Prescott SM; Stafforini DM
FASEB J; 2007 Apr; 21(4):1164-76. PubMed ID: 17210780
[TBL] [Abstract][Full Text] [Related]
14. Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress.
Noto H; Hara M; Karasawa K; Iso-O N; Satoh H; Togo M; Hashimoto Y; Yamada Y; Kosaka T; Kawamura M; Kimura S; Tsukamoto K
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):829-35. PubMed ID: 12649088
[TBL] [Abstract][Full Text] [Related]
15. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase.
Tsironis LD; Mitsios JV; Milionis HJ; Elisaf M; Tselepis AD
Cardiovasc Res; 2004 Jul; 63(1):130-8. PubMed ID: 15194469
[TBL] [Abstract][Full Text] [Related]
16. Plasma platelet-activating factor-acetyl hydrolase activity and the levels of free forms of biomarker of lipid peroxidation in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage.
Hirashima Y; Doshi M; Hayashi N; Endo S; Akazawa Y; Shichiri M; Yoshida Y
Neurosurgery; 2012 Mar; 70(3):602-9. PubMed ID: 21866060
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated gene transfer and lipoprotein-mediated protein delivery of plasma PAF-AH ameliorates proteinuria in rat model of glomerulosclerosis.
Iso-O N; Noto H; Hara M; Togo M; Karasawa K; Ohashi N; Noiri E; Hashimoto Y; Kadowaki T; Kimura S; Watanabe T; Tsukamoto K
Mol Ther; 2006 Jan; 13(1):118-26. PubMed ID: 16213192
[TBL] [Abstract][Full Text] [Related]
18. Bovine platelet-activating factor acetylhydrolase (PAF-AH) activity related to fertility.
Turk R; Juretić D; Geres D; Bacić G; Milesević M; Flegar-Mestrić Z; Turk N; Svetina A
Anim Reprod Sci; 2008 May; 105(3-4):344-53. PubMed ID: 17442508
[TBL] [Abstract][Full Text] [Related]
19. Identification of a domain that mediates association of platelet-activating factor acetylhydrolase with high density lipoprotein.
Gardner AA; Reichert EC; Topham MK; Stafforini DM
J Biol Chem; 2008 Jun; 283(25):17099-106. PubMed ID: 18434304
[TBL] [Abstract][Full Text] [Related]
20. cDNA cloning and expression of biologically active platelet activating factor-acetylhydrolase (PAF-AH) from bovine mammary gland.
Lee E; Lee SJ; Lee TY; Chang HW
Biol Pharm Bull; 2005 Apr; 28(4):580-3. PubMed ID: 15802790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
